Literature DB >> 7219632

Plasma factor XIII levels in children with renal disease.

K Yoshioka, H Miyata, Y Uraoka, S Maki.   

Abstract

Plasma levels of coagulation factor XIII determined quantitatively were found to have a tendency to be decreased in more severely affected cases of acute poststreptococcal glomerulonephritis and Henoch-Schönlein nephritis, and found to be decreased in patients with rapidly progressive glomerulonephritis and chronic renal failure in comparison with normal controls. It seems that the degree of decrease in factor XIII reflects the intensity of glomerular damage. In contrast, the patients with the nephrotic syndrome showed significant elevation of plasma factor XIII levels and it was closely correlated with the increase in serum triglycerides. The elevation of factor XIII levels in the nephrotic syndrome is suggested to be mainly attributed to enhanced protein synthesis in connection with urinary loss of proteins.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7219632     DOI: 10.1159/000182014

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  4 in total

Review 1.  The rheumatic poison: a survey of some published investigations of the immunopathogenesis of Henoch-Schönlein purpura.

Authors:  J F Knight
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

2.  Coagulation abnormalities in chronic peritoneal dialysis.

Authors:  C L Jones; M Andrew; A Eddy; M O'Neil; N I Shalom; J W Balfe
Journal:  Pediatr Nephrol       Date:  1990-03       Impact factor: 3.714

3.  Localisation of factor XIII in human tissues using an immunoperoxidase technique.

Authors:  J D Fear; P Jackson; C Gray; K J Miloszewski; M S Losowsky
Journal:  J Clin Pathol       Date:  1984-05       Impact factor: 3.411

4.  Effect of corticosteroids on coagulation factors in children with nephrotic syndrome.

Authors:  N Ueda; S Kawaguchi; Y Niinomi; T Nonoda; J Matsumoto; M Ohnishi; T Yasaki
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.